Ketamine shows potential for rapid and sustained anxiety relief
A recent meta-analysis published in the Journal of Psychopharmacology indicates that subanesthetic doses of ketamine may provide rapid and sustained relief from anxiety, with effects noticeable within a few hours and lasting up to two weeks. However, the researchers stress...
New research highlights ketamine’s unexpected aggression side effects in rodent models of early life stress
Ketamine tends to increase early life stress-induced aggression in rodent models, but it does not induce significant effects on other behavioral measures related to mood disorders, such as fear memory, anxiety-like behavior, and depression-like behavior, according to new research published...
Rapid neuroplasticity changes are associated with ketamine treatment response in patients with depression
A recent study found that the antidepressant effects of intravenous ketamine treatment are linked to rapid changes in neuroplasticity. The study analyzed data from depressed individuals who received ketamine or a placebo, revealing that increased neuroplasticity in specific brain regions...
Real-world analysis confirms ketamine infusion therapy as powerful treatment for depression and anxiety
A recent study found that ketamine infusion therapy was associated with a significant reduction in self-reported symptoms of anxiety, depression, and suicidality, with stable effects observed during the maintenance phase. The study, published in the Journal of Affective Disorders, provides...
Ketamine shows promise in the treatment of depression in patients with borderline personality disorder
New research provides evidence that ketamine therapy might be a suitable option for adults with borderline personality disorder and treatment-resistant depression. The new findings have been published in Psychiatry Research.
PsyPost Merch
